Improvement in wound healing by a novel synthetic collagen-gel dressing in genetically diabetic mice

Asian Journal of Oral and Maxillofacial Surgery

Volumn 22, Issue 2, 2010, Pages 61-67

  Chikazu, Daichi ^a   Taguchi, Tetsushi ^b   Koyama, Hiroyuki ^a   Hikiji, Hisako ^a   Fujihara, Hisako ^a   Suenaga, Hideyuki ^a   Saijo, Hideto ^a   Mori, Yoshiyuki ^a   Seto, Ichiro ^a   Iino, Mitsuyoshi ^a   Takato, Tsuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

Collagen gel dressing; Diabetic mice; Wound healing

Indexed keywords

EID: 77956010469     PISSN: 09156992     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajoms.2010.01.001     Document Type: Article

References (29)

1. Cope O. Treatment of surface burns. Ann Surg 1943, 117:885-893.
2. Gimbel N.S., Kapetansky D.I., Weissman F., Pinkus H.K.B. A study of epithelization in blistered burns. AMA Arch Surg 1957, 74:800-803.
3. Winter G.D. Formation of scab and rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962, 193:293-294.
4. Hinman C.D., Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963, 200:377-378.
5. Friede H., Enemark H., Semb G., Paulin G., Abyholm F., Bolund S., et al. Craniofacial and occlusal characteristic in unilateral cleft lip and palate patients from four Scandinavian centers. Scand J Plast Reconstr Hand Surg 1991, 25:269-276.
6. Koide M., Osaki K., Konishi J., Oyamada K., Katakura T., Takahashi A. A new type of biomaterial for artificial skin; dehydrothermally cross-linked composites of fibrillar and denatured collagens. J Biomed Mater Res 1993, 27:79-87.
7. Soejima K., Nozaki M., Sasaki K., Takeuchi M., Negishi N. Reconstruction of burn deformity using artificial dermis combined with thin split-skin grafting. Burns 1997, 23:501-504.
8. Taguchi T., Saito H., Uchida Y., Sakane M., Kobayashi H., Kataoka K., et al. Bonding of soft tissues using a novel tissue adhesive consisting of a citric acid derivative and collagen. Mater Sci Eng C 2004, 24:775-780.
9. Saito H., Taguchi T., Aoki H., Murabayashi S., Mitamura Y., Tanaka J., et al. pH-responsive swelling behavior of collagen gels prepared by novel crosslinkers based on naturally derived di- or tricarboxylic acids. Acta Biomater 2007, 3:89-94.
10. Saito H., Taguchi T., Kobayashi H., Kataoka K., Tanaka J., Murabayashi S., et al. Physicochemical properties of gelatin gels prepared using citric acid derivative. Mater Sci Eng C 2004, 24:781-785.
11. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
12. Delbridge L., Ctertcteko G.H., Fowler C., Reeve T.S., Le Quesne L.P. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 1985, 72:1-6.
13. Yannas I.V., Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980, 14:65-81.
14. Burke J.F., Yannas I.V., Quinby W.C., Bondoc C.C., Jung W.K. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981, 194:413-428.
15. Stenzel K.H., Miyata T., Rubin A.L. Collagen as a biomaterial. Annu Rev Biophys Bioeng 1974, 3:231-253.
16. McPherson J.M., Ledger P.W., Sawamura S., Conti A., Wade S., Reihanian H., et al. The preparation and physicochemical characterization of an injectable form of reconstituted, glutaraldehyde cross-linked, bovine corium collagen. J Biomed Mater Res 1986, 20:79-92.
17. Yoshizato K., Taira T., Yamamoto N. Growth inhibition of human fibroblasts by reconstituted collagen fibrils. Biomed Res 1985, 6:61-71.
18. Saito H., Murabayashi S., Mitamura Y., Taguchi T. Unusual cell adhesion and antithrombogenic behavior of citric acid-cross-linked collagen matrices. Biomacromolecules 2007, 8:1992-1998.
19. McGee G.S., Davidson J.M., Buckley A., Sommer A., Woodward S.C., Aquino A.M., et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988, 45:145-153.
20. Rifkin D.B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989, 109:1-6.
21. Klingbeil C.K., Cesar L.B., Fiddes J.C. Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res 1991, 365:443-458.
22. Okumura M., Okuda T., Nakamura T., Yajima M. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996, 19:530-535.
23. Yamada K., Tabata Y., Yamamoto K., Miyamoto S., Nagata I., Kikuchi H., et al. Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 1997, 86:871-875.
24. Kawai K., Suzuki S., Tabata Y., Ikada Y., Nishimura Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 2000, 21:489-499.
25. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcD716 knockout mice. Nat Med 2001, 7:1048-1051.
26. Leahy K.M., Ornberg R.L., Wang Y., Zweifel B.S., Koki A.T., Masferrer J.L. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002, 62:625-631.
27. 2 production that modulate motility. J Biol Chem 2004, 279:55905-55913.
28. Jones M.K., Wang H., Peskar B.M., Levin E., Itani R.M., Sarfeh I.J., et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5:1418-1423.
29. 3-expressing bone marrow cells is crucial in wound induced angiogenesis. Am J Pathol 2006, 169:1458-1472.